FR2316943B1 - - Google Patents

Info

Publication number
FR2316943B1
FR2316943B1 FR7619563A FR7619563A FR2316943B1 FR 2316943 B1 FR2316943 B1 FR 2316943B1 FR 7619563 A FR7619563 A FR 7619563A FR 7619563 A FR7619563 A FR 7619563A FR 2316943 B1 FR2316943 B1 FR 2316943B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7619563A
Other languages
French (fr)
Other versions
FR2316943A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of FR2316943A1 publication Critical patent/FR2316943A1/fr
Application granted granted Critical
Publication of FR2316943B1 publication Critical patent/FR2316943B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7619563A 1975-06-27 1976-06-28 Pyrrolidones et medicaments qui en contiennent Granted FR2316943A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752528664 DE2528664A1 (de) 1975-06-27 1975-06-27 Pyrrolidone und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
FR2316943A1 FR2316943A1 (fr) 1977-02-04
FR2316943B1 true FR2316943B1 (enExample) 1978-11-03

Family

ID=5950059

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7619563A Granted FR2316943A1 (fr) 1975-06-27 1976-06-28 Pyrrolidones et medicaments qui en contiennent

Country Status (14)

Country Link
JP (1) JPS525764A (enExample)
AT (1) AT365575B (enExample)
BE (1) BE843505A (enExample)
CH (1) CH623809A5 (enExample)
DE (1) DE2528664A1 (enExample)
DK (1) DK287476A (enExample)
ES (1) ES449095A1 (enExample)
FR (1) FR2316943A1 (enExample)
GB (1) GB1553595A (enExample)
IL (1) IL49916A0 (enExample)
LU (1) LU75235A1 (enExample)
NL (1) NL7606773A (enExample)
SE (1) SE7607331L (enExample)
ZA (1) ZA763802B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1077948A (en) * 1976-08-06 1980-05-20 Albin J. Nelson 1,-5 disubstituted-2-pyrrolidones and processes for their production
US4772601A (en) * 1988-01-25 1988-09-20 Hoechst-Roussel Pharmaceuticals, Inc. 5-Substituted 1-(4-(1-pyrrolidinyl)-2-butynyl)-2-pyrrolidinones, pharmaceutical compositions and use
PL356662A1 (en) * 1999-12-22 2004-06-28 Pfizer Products Inc. Ep4 receptor selective agonists in the treatment of osteoporosis
AU2001290250A1 (en) * 2000-09-21 2002-04-02 Ono Pharmaceutical Co. Ltd. Ep4 receptor agonists containing 8-azaprostaglandin derivatives as the active ingredient
BR0115687A (pt) 2000-11-27 2003-09-09 Pfizer Prod Inc Agonistas seletivos do receptor ep4 no tratamento de osteoporose
JP2004521954A (ja) 2001-07-16 2004-07-22 エフ.ホフマン−ラ ロシュ アーゲー Ep4受容体作用薬としてのプロスタグランジン類似体
MXPA04000454A (es) 2001-07-16 2004-03-18 Hoffmann La Roche Derivados de 2-pirrolidona como agonistas de prostanoides.
DE60239343D1 (de) 2001-07-23 2011-04-14 Ono Pharmaceutical Co Mittel zur behandlung von erkrankungen, die mit knochenschwund einhergehen, mit ep4-agonist als wirkstoff
WO2003077910A1 (en) * 2002-03-18 2003-09-25 Pfizer Products Inc. Methods of treatment with selective ep4 receptor agonists
US6573294B1 (en) * 2002-05-14 2003-06-03 Allergan, Inc. 8-azaprostaglandin analogs as agents for lowering intraocular pressure
EP1585729A1 (en) 2003-01-10 2005-10-19 F.Hoffmann-La Roche Ag 2-piperidone derivatives as prostaglandin agonists
US7179820B2 (en) 2003-06-06 2007-02-20 Allergan, Inc. Piperidinyl prostaglandin E analogs
EP2875022B1 (en) 2012-07-19 2016-10-12 Cayman Chemical Company, Incorporated Difluorolactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated disease and conditions
US9676712B2 (en) 2013-03-15 2017-06-13 Cayman Chemical Company, Inc. Lactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions
JP6368351B2 (ja) 2013-03-15 2018-08-01 ケイマン ケミカル カンパニー, インコーポレーテッド ジフルオロラクタムアナログを合成する方法
BR112015023080A2 (pt) 2013-03-15 2017-07-18 Cayman Chemical Co Inc composto, composição farmacêutica, e, método para tratamento de doenças
KR20160048054A (ko) 2013-07-19 2016-05-03 카이맨 케미칼 컴파니 인코포레이티드 골 성장의 촉진을 위한 방법, 시스템 및 조성물

Also Published As

Publication number Publication date
ES449095A1 (es) 1977-12-16
SE7607331L (sv) 1976-12-28
JPS525764A (en) 1977-01-17
DE2528664A1 (de) 1977-01-13
IL49916A0 (en) 1976-08-31
LU75235A1 (enExample) 1977-03-16
NL7606773A (nl) 1976-12-29
ATA467976A (de) 1981-06-15
CH623809A5 (en) 1981-06-30
FR2316943A1 (fr) 1977-02-04
AT365575B (de) 1982-01-25
BE843505A (fr) 1976-12-28
GB1553595A (en) 1979-09-26
DK287476A (da) 1976-12-28
ZA763802B (en) 1977-05-25

Similar Documents

Publication Publication Date Title
CH599666A5 (enExample)
CH601406A5 (enExample)
BG21720A1 (enExample)
BG21736A1 (enExample)
BG22242A1 (enExample)
BG22318A1 (enExample)
BG22893A1 (enExample)
BG23322A1 (enExample)
CH580195A5 (enExample)
CH586152A5 (enExample)
CH586518A5 (enExample)
CH588917A5 (enExample)
CH589550A5 (enExample)
CH589963A5 (enExample)
CH590430A5 (enExample)
CH590631A5 (enExample)
CH591151A5 (enExample)
CH591716A5 (enExample)
CH592273A5 (enExample)
CH592305A5 (enExample)
CH592460A5 (enExample)
CH592940A5 (enExample)
CH593108A5 (enExample)
CH593744A5 (enExample)
CH595226A5 (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse